ILK and breast cancer: Previous study showed that syntenin positively regulates the ILK adaptor function for the assembly of integrin β1/IPP signaling complexes, which activate integrin signaling pathways, including AKT, ERK1/2, and Rac1, in breast cancer cells [18].